Cardio Diagnostics Holdings Stock Today
| CDIOW Stock | USD 0.07 0.01 8.50% |
Performance0 of 100
| Odds Of DistressOver 85
|
Cardio Diagnostics is selling for under 0.07 as of the 1st of May 2024; that is -8.5 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.07. Cardio Diagnostics has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Cardio Diagnostics Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of April 2024 and ending today, the 1st of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 14th of January 2022 | Category Healthcare | Classification Health Care |
Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.. The company has 0 outstanding shares of which 44.58 K shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Cardio Diagnostics Holdings
Moving together with Cardio Stock
| 0.82 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
Moving against Cardio Stock
| 0.83 | HCM | HUTCHMED DRC | PairCorr |
| 0.65 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.63 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.6 | FLGC | Flora Growth Corp Buyout Trend | PairCorr |
| 0.45 | BHC | Bausch Health Companies Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Cardio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cardio Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cardio Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO CoFounder | Meeshanthini Dogan | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Cardio Diagnostics' liquidity, profitability, solvency, and operating efficiency, Cardio Diagnostics Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Cardio Diagnostics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Cardio Diagnostics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cardio Diagnostics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardio Diagnostics' financial leverage. It provides some insight into what part of Cardio Diagnostics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Cardio Diagnostics Holdings (CDIOW) is traded on NASDAQ Exchange in USA. It is located in 400 North Abderdeen Street, Chicago, IL, United States, 60642 and employs 7 people. Cardio Diagnostics is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Cardio Diagnostics has 0 outstanding shares of which 44.58 K shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions.
Cardio Diagnostics generates negative cash flow from operations
Check Cardio Diagnostics Probability Of Bankruptcy
Cardio Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Cardio Diagnostics jumping above the current price in 90 days from now is about 90.18%. The Cardio Diagnostics Holdings probability density function shows the probability of Cardio Diagnostics stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Cardio Diagnostics Holdings has a beta of -5.0417 suggesting as returns on its benchmark rise, returns on holding Cardio Diagnostics Holdings are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Cardio Diagnostics is expected to outperform its benchmark. Additionally, cardio Diagnostics Holdings has an alpha of 0.1393, implying that it can generate a 0.14 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Cardio Diagnostics to move above the current price in 90 days from now is about 90.18 (This Cardio Diagnostics Holdings probability density function shows the probability of Cardio Stock to fall within a particular range of prices over 90 days) .
Cardio Diagnostics Historical Income Statement
Cardio Diagnostics Holdings Income Statement is one of the three primary financial statements used for reporting Cardio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cardio Diagnostics revenue and expense. Cardio Diagnostics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Cardio Diagnostics' Selling General Administrative is fairly stable compared to the past year. Total Revenue is likely to climb to about 17.9 K in 2024, despite the fact that Operating Income is likely to grow to (6.9 M). View More FundamentalsCardio Stock Against Markets
Picking the right benchmark for Cardio Diagnostics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cardio Diagnostics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cardio Diagnostics is critical whether you are bullish or bearish towards Cardio Diagnostics Holdings at a given time. Please also check how Cardio Diagnostics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cardio Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Cardio Diagnostics Corporate Management
Elected by the shareholders, the Cardio Diagnostics' board of directors comprises two types of representatives: Cardio Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardio. The board's role is to monitor Cardio Diagnostics' management team and ensure that shareholders' interests are well served. Cardio Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardio Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Esq JD | Chief Officer | Profile | |
| Timur Dogan | Chief Officer | Profile | |
| Khullani JD | Vice Strategy | Profile | |
| MBA JD | CFO Director | Profile | |
| Khullani Abdullah | VP Strategy | Profile |
How to buy Cardio Stock?
Before investing in Cardio Diagnostics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cardio Diagnostics. To buy Cardio Diagnostics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cardio Diagnostics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Cardio Diagnostics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Cardio Diagnostics Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Cardio Diagnostics Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cardio Diagnostics Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Cardio Stock please use our How to Invest in Cardio Diagnostics guide.
Already Invested in Cardio Diagnostics Holdings?
The danger of trading Cardio Diagnostics Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cardio Diagnostics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cardio Diagnostics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cardio Diagnostics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Cardio Diagnostics is a strong investment it is important to analyze Cardio Diagnostics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardio Diagnostics' future performance. For an informed investment choice regarding Cardio Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Cardio Stock analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Cardio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Quarterly Revenue Growth 4.589 | Return On Assets (0.85) | Return On Equity (2.31) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.